Pa. Havre et Pm. Glazer, TARGETED MUTAGENESIS OF SIMIAN VIRUS-40 DNA-MEDIATED BY A TRIPLE HELIX-FORMING OLIGONUCLEOTIDE, Journal of virology, 67(12), 1993, pp. 7324-7331
Triple-helical DNA can be formed by oligonucleotides that bind as thir
d strands of DNA in a sequence-specific manner in the major groove in
homopurine/homopyrimidine stretches in duplex DNA. Such triple helix-f
orming oligonucleotides have been used to inhibit gene expression by b
locking transcription factor access to promoter sites in transient exp
ression assays. In an alternative approach to genetic manipulation usi
ng triplex DNA, we show that triplex-forming oligonucleotides can be u
sed to produce site-specific, targeted mutations in a viral genome in
order to achieve a permanent, heritable effect on gene function and ex
pression. We use a triplex-forming oligonucleotide linked to a psorale
n derivative at its 5' end to achieve targeted mutagenesis in a simian
virus 40 (SV40) vector genome. Site-specific triplex formation delive
rs the psoralen to the targeted site in the SV40 DNA. Photoactivation
of the psoralen yields adducts and thereby mutations at that site. Mut
ations were produced in the target gene in over 6% of the viral genome
s. DNA sequence analysis of the mutations in the target gene showed th
at all were in the targeted region, and 55% were found to be the same
T:A-to-A:T transversion precisely at the targeted base pair. In contro
l experiments, no mutagenesis above the background frequency in the as
say was produced by a non-triplex-forming, psoralen-linked oligonucleo
tide unless a vast excess of this oligonucleotide was used, demonstrat
ing the specificity of the targeted mutagenesis. This frequency of tar
geted mutagenesis of SV40 in monkey cells represents a 30-fold increas
e relative to similar experiments using lambda phage in bacteria, sugg
esting that fixation of the triplex-directed lesion into a mutation oc
curs more efficiently in mammalian cells. If the ability to reproducib
ly and predictably target mutations to sites in viral DNA in vitro by
using modified oligonucleotides can be extended to DNA in vivo, this a
pproach may prove useful as a technique for gene therapy, as a strateg
y for antiviral therapeutics, and as a tool for genetic engineering.